Philip M. Diller

Family Medicine

11590 Century Blvd
Cincinnati, OH 45246

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Alirocumab for hyperlipidemia: physiology of PCSK9 inhibition, pharmacodynamics and Phase I and II clinical trial results of a PCSK9 monoclonal antibody.

Alirocumab for hyperlipidemia: physiology of PCSK9 inhibition, pharmacodynamics and Phase I and II clinical trial results of a PCSK9 monoclonal antibody.

Journal: Future cardiology

Published: April 26, 2014

Showing 1-1 of 1

Last Updated: 09/26/2026